74 companies · 127 connections
AI drug discovery using AlphaFold-derived protein interaction models
| Founded | 2021 |
| HQ | King's Cross, London |
| Founders | Demis Hassabis |
| Funding | $600M |
| Valuation | Alphabet subsidiary |
| Team | 200+ |
Pharma R&D (internal Alphabet + partnerships)
$600M Series A (2025), $3B Eli Lilly and Novartis partnerships
Isomorphic Labs is tracked by LDN/ai as part of London's AI ecosystem. The company focuses on ai drug discovery using alphafold-derived protein interaction models.
View on the LDN/ai interactive map →
Baseimmune · BenevolentAI · Causaly · Hologen
View the full ecosystem guide →